Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2312.3 and 2342.2
| Intraday Target 1 | 2306.53 |
| Intraday Target 2 | 2318.07 |
| Intraday Target 3 | 2336.4333333333 |
| Intraday Target 4 | 2347.97 |
| Intraday Target 5 | 2366.33 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 19 January 2026 | 2329.60 (-0.67%) | 2345.90 | 2324.90 - 2354.80 | 0.3742 times | Fri 16 January 2026 | 2345.40 (-2.06%) | 2409.80 | 2340.00 - 2409.80 | 0.9691 times | Wed 14 January 2026 | 2394.80 (1.08%) | 2369.00 | 2361.00 - 2411.50 | 0.9161 times | Tue 13 January 2026 | 2369.10 (-1.17%) | 2397.00 | 2349.00 - 2417.10 | 0.9571 times | Mon 12 January 2026 | 2397.10 (1.05%) | 2372.00 | 2337.60 - 2403.80 | 0.7262 times | Fri 09 January 2026 | 2372.10 (-1.11%) | 2390.00 | 2350.00 - 2404.00 | 1.3295 times | Thu 08 January 2026 | 2398.70 (-2.48%) | 2455.00 | 2386.80 - 2455.30 | 0.7173 times | Wed 07 January 2026 | 2459.80 (-0.95%) | 2483.30 | 2448.00 - 2528.00 | 2.5435 times | Tue 06 January 2026 | 2483.30 (1.1%) | 2456.00 | 2437.20 - 2504.00 | 0.7452 times | Mon 05 January 2026 | 2456.20 (-1.11%) | 2484.90 | 2452.00 - 2484.90 | 0.7218 times | Fri 02 January 2026 | 2483.80 (1.14%) | 2461.30 | 2443.90 - 2487.70 | 0.4485 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2312.3 and 2342.2
| Weekly Target 1 | 2306.53 |
| Weekly Target 2 | 2318.07 |
| Weekly Target 3 | 2336.4333333333 |
| Weekly Target 4 | 2347.97 |
| Weekly Target 5 | 2366.33 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 19 January 2026 | 2329.60 (-0.67%) | 2345.90 | 2324.90 - 2354.80 | 0.0612 times | Fri 16 January 2026 | 2345.40 (-1.13%) | 2372.00 | 2337.60 - 2417.10 | 0.5839 times | Fri 09 January 2026 | 2372.10 (-4.5%) | 2484.90 | 2350.00 - 2528.00 | 0.9911 times | Fri 02 January 2026 | 2483.80 (0.79%) | 2483.00 | 2362.60 - 2487.70 | 2.0066 times | Fri 26 December 2025 | 2464.30 (-2.56%) | 2530.10 | 2459.50 - 2550.10 | 0.4766 times | Fri 19 December 2025 | 2529.00 (-2.76%) | 2587.70 | 2506.70 - 2608.90 | 0.8751 times | Fri 12 December 2025 | 2600.80 (2.17%) | 2545.60 | 2491.00 - 2635.00 | 1.3695 times | Fri 05 December 2025 | 2545.60 (-0.93%) | 2551.00 | 2461.10 - 2582.50 | 1.4191 times | Fri 28 November 2025 | 2569.50 (2.87%) | 2497.90 | 2404.20 - 2585.10 | 1.1479 times | Fri 21 November 2025 | 2497.90 (0.75%) | 2491.70 | 2471.40 - 2532.60 | 1.0691 times | Fri 14 November 2025 | 2479.40 (-4.19%) | 2587.00 | 2467.50 - 2590.60 | 1.4729 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2225.7 and 2428.8
| Monthly Target 1 | 2191.07 |
| Monthly Target 2 | 2260.33 |
| Monthly Target 3 | 2394.1666666667 |
| Monthly Target 4 | 2463.43 |
| Monthly Target 5 | 2597.27 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 19 January 2026 | 2329.60 (-5.82%) | 2476.00 | 2324.90 - 2528.00 | 0.2651 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 0.8694 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 0.7251 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.4709 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 0.7501 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.038 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.6338 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.2681 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 2.2771 times | Wed 30 April 2025 | 2964.60 (2.92%) | 2872.00 | 2401.00 - 3148.00 | 1.7024 times | Fri 28 March 2025 | 2880.35 (16.36%) | 2485.00 | 2390.05 - 2988.00 | 1.1839 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2225.7 and 2428.8
| Yearly Target 1 | 2191.07 |
| Yearly Target 2 | 2260.33 |
| Yearly Target 3 | 2394.1666666667 |
| Yearly Target 4 | 2463.43 |
| Yearly Target 5 | 2597.27 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 19 January 2026 | 2329.60 (-5.82%) | 2476.00 | 2324.90 - 2528.00 | 0.039 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.7028 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2978 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2774 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7419 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9897 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.1044 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4724 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2403 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1344 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1346 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
And this trend seems to be continuing further.Price is below an important level of 2401.1 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 30 as on Mon 19 January 2026
This Munafa value indicates that the stock is moving downwards and might continue to move down.
SMA20 is at 2440 and price is deviating by 59 points
Upper Bollinger band is at 2556 and lower is at 2323, while middle bands are at 2381 and 2498
Price is coming down
Price is below 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and the sell signal is strong.
GlaxosmithklinePharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of GlaxosmithklinePharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2410.1 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2367.2 |
| 12 day DMA | 2412.15 |
| 20 day DMA | 2439.24 |
| 35 day DMA | 2490.42 |
| 50 day DMA | 2494.56 |
| 100 day DMA | 2617.52 |
| 150 day DMA | 2775.55 |
| 200 day DMA | 2823.62 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2363.04 | 2379.76 | 2396.94 |
| 12 day EMA | 2401.1 | 2414.09 | 2426.58 |
| 20 day EMA | 2431.21 | 2441.9 | 2452.05 |
| 35 day EMA | 2462.16 | 2469.96 | 2477.29 |
| 50 day EMA | 2493.38 | 2500.06 | 2506.37 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2367.2 | 2375.7 | 2386.36 |
| 12 day SMA | 2412.15 | 2424.15 | 2427.38 |
| 20 day SMA | 2439.24 | 2450.47 | 2462.33 |
| 35 day SMA | 2490.42 | 2495.85 | 2499.96 |
| 50 day SMA | 2494.56 | 2500.08 | 2506.34 |
| 100 day SMA | 2617.52 | 2622.22 | 2626.57 |
| 150 day SMA | 2775.55 | 2782.15 | 2789.04 |
| 200 day SMA | 2823.62 | 2826.15 | 2828.52 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.39 and PE is: 41.31
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
EPS is 56.09 and PE is: 41.53
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
